Immunic, Inc. (IMUX) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Immunic, Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMUX
Immunic, Inc.
$8.10HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
LENZ
LENZ Therapeutics, Inc.
$3.80HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
Total return — IMUX vs LENZ
growth of $100 · dividends reinvested · last 5yIMUX -93.3% (-41.8%/yr)LENZ -91.4% (-38.7%/yr)LENZ compounded faster over this window
IMUX LENZ
IMUX vs LENZ: by the numbers
- •LENZ is the larger company ($119M vs $110M market cap).
- •Both run net losses; IMUX's is the smaller (0.00% vs -586.74% net margin).
Metrics side by side
Valuation
| Metric | IMUX | LENZ |
|---|---|---|
| P/S ratio | N/A | 5.55 |
| P/B ratio | 0.86 | 0.54 |
Profitability
| Metric | IMUX | LENZ |
|---|---|---|
| Gross margin | 0.00% | 90.14% |
| Operating margin | 0.00% | -477.46% |
| Net margin | 0.00% | -586.74% |
| ROE | -87.45% | -57.47% |
| ROIC | -92.16% | -61.84% |
Growth (annualized)
| Metric | IMUX | LENZ |
|---|---|---|
| Total return CAGR (5Y) | -35.70% | -35.49% |
Frequently asked
- How have IMUX and LENZ total returns compared?
- Over the past 5 years, IMUX delivered -35.70% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.